AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.80
+0.20 (1.89%)
Mar 16, 2026, 12:12 PM EDT - Market open
AngioDynamics Employees
AngioDynamics had 675 employees as of May 31, 2025. The number of employees decreased by 73 or -9.76% compared to the previous year.
Employees
675
Change (1Y)
-73
Growth (1Y)
-9.76%
Revenue / Employee
$455,268
Profits / Employee
-$41,052
Market Cap
445.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| May 31, 2025 | 675 | -73 | -9.76% |
| May 31, 2024 | 748 | -67 | -8.22% |
| May 31, 2023 | 815 | 55 | 7.24% |
| May 31, 2022 | 760 | -40 | -5.00% |
| May 31, 2021 | 800 | 0 | - |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Azenta | 3,000 |
| Embecta | 1,850 |
| STAAR Surgical Company | 1,157 |
| OraSure Technologies | 501 |
| Anteris Technologies Global | 174 |
| Utah Medical Products | 167 |
| BioLife Solutions | 155 |
| Sanara MedTech | 141 |
ANGO News
- 20 days ago - AngioDynamics to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 25 days ago - AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform - Business Wire
- 5 weeks ago - AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care - Business Wire
- 5 weeks ago - AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance - Business Wire
- 2 months ago - AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability - Business Wire
- 2 months ago - AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga